{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T01:59:41Z","timestamp":1776304781834,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":3525,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HD 053112"],"award-info":[{"award-number":["HD 053112"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.fertnstert.2012.06.015","type":"journal-article","created":{"date-parts":[[2012,7,7]],"date-time":"2012-07-07T00:48:10Z","timestamp":1341622090000},"page":"961-964.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer?"],"prefix":"10.1016","volume":"98","author":[{"given":"Sanghoon","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kutluk","family":"Oktay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2012.06.015_bib2","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1200\/JCO.2006.06.5888","article-title":"American Society of Clinical Oncology recommendations on fertility preservation in cancer patients","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2012.06.015_bib3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1470-2045(05)70070-X","article-title":"Fertility preservation: an emerging discipline in the care of young patients with cancer","volume":"6","author":"Oktay","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.fertnstert.2012.06.015_bib4","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1200\/JCO.2007.14.8700","article-title":"Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study","volume":"26","author":"Azim","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2012.06.015_bib5","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1200\/JCO.2010.30.5748","article-title":"Value of early referral to fertility preservation in women with breast cancer","volume":"28","author":"Lee","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2012.06.015_bib6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2009.24.2057","article-title":"Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast\/ovarian cancer risks","volume":"28","author":"Oktay","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2012.06.015_bib7","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.fertnstert.2007.05.055","article-title":"Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in\u00a0vitro fertilization","volume":"89","author":"Pal","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.06.015_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/humupd\/dmp012","article-title":"Approaches to improve the diagnosis and management of infertility","volume":"15","author":"Devroey","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2012.06.015_bib9","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/humrep\/del484","article-title":"Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial","volume":"22","author":"Baart","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.06.015_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10815-008-9266-6","article-title":"Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve","volume":"25","author":"Lekamge","year":"2008","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2012.06.015_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/carcin\/bgq255","article-title":"Estrogen receptor alpha\u2013mediated transcription induces cell cycle-dependent DNA double-strand breaks","volume":"32","author":"Williamson","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.fertnstert.2012.06.015_bib12","doi-asserted-by":"crossref","first-page":"782","DOI":"10.18632\/aging.100363","article-title":"Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise","volume":"3","author":"Soleimani","year":"2011","journal-title":"Aging"},{"key":"10.1016\/j.fertnstert.2012.06.015_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/humupd\/dmq041","article-title":"Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in\u00a0vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis","volume":"17","author":"Sterrenburg","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2012.06.015_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.bjc.6602734","article-title":"Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)","volume":"93","author":"Cold","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2012.06.015_bib15","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.fertnstert.2008.01.034","article-title":"Cost-saving treatment strategies in in\u00a0vitro fertilization: a combined economic evaluation of two large randomized clinical trials comparing highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone alpha","volume":"91","author":"Wechowski","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.06.015_bib16","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/humrep\/deg311","article-title":"Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility","volume":"18","author":"Mitwally","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.06.015_bib17","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1210\/jc.2006-0962","article-title":"Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy","volume":"91","author":"Oktay","year":"2006","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028212006504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028212006504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T16:16:47Z","timestamp":1775233007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028212006504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0015028212006504"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2012.06.015","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer?","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2012.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}